Outcomes

N = 25

Skin irritation, % (n)

44.0 (11)

Skin Erythema, % (n)

100.0 (25)

Catheter absent infection occurrence

28.0 (7)

Discontinuation of the CIGD, % (n)

24.0 (6)

Central-line associated bloodstream infection, % (n)

32.0 (8)